• Monday, April 4, 2022 @ 12:00 am

"We have been delighted to learn that AC BioScience has been awarded Gold status by the Investor Network of the European Institute of Innovation and Technology (EIT). This is a great recognition of the company's compelling science and business case", said Andreas Schläpfer, Co-founder and CEO of AC BioScience. The EIT is a network of best-in-class innovators co-funded by the European Union. Its Investor Network connects qualified companies seeking funding with the first pan-European consortium of more than 80 healthcare investors across 18 countries.

You may also be interested in